Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes, JAMA, vol.291, issue.3, pp.335-342, 2004. ,
DOI : 10.1001/jama.291.3.335
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American diabetes association (ADA) and the European association for the study of diabetes (EASD), Diabetologia, vol.55, pp.577-596, 2012. ,
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes, New England Journal of Medicine, vol.359, issue.15, pp.1577-1589, 2008. ,
DOI : 10.1056/NEJMoa0806470
DG1: THE RELATIONSHIP OF DIABETES SYMPTOMS AND HEALTH-RELATED QUALITY OF LIFE, Value in Health, vol.4, issue.2, p.58, 2001. ,
DOI : 10.1046/j.1524-4733.2001.40201-29.x
Understanding the Social Factors That Contribute to Diabetes: A Means to Informing Health Care and Social Policies for the Chronically Ill, The Permanente Journal, vol.17, issue.2, pp.67-72, 2013. ,
DOI : 10.7812/TPP/12-099
Personalized management of hyperglycemia in type 2 diabetes. Diabetes Care, pp.1779-1788, 2013. ,
Quality of life and diabetes, Diabetes/Metabolism Research and Reviews, vol.47, issue.3, pp.205-218, 1999. ,
DOI : 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
Relationship of Health-Related Quality of Life to Symptom Severity in Diabetes Mellitus, Journal of Clinical Epidemiology, vol.52, issue.8, pp.773-780, 1999. ,
DOI : 10.1016/S0895-4356(99)00053-0
Health-related quality of life deficits associated with varying degrees of disease severity in type 2 diabetes, Health and Quality of Life Outcomes, vol.1, issue.1, p.78, 2003. ,
DOI : 10.1186/1477-7525-1-78
Patient-reported outcomes in trials of incretin-based therapies in patients with type 2 diabetes mellitus, Diabetes, Obesity and Metabolism, vol.41, issue.Suppl. 1, pp.882-892, 2012. ,
DOI : 10.1111/j.1463-1326.2012.01595.x
Clinical outcomes and costs for patients with type 2 diabetes mellitus initiating insulin therapy in Greece: two-year experience from the INSTIGATE study. Prim Care Diabetes 2013 ,
Glycaemia and correlates of patient-reported outcomes in ACCORD trial participants, Diabetic Medicine, vol.17, issue.7, pp.67-74, 2012. ,
DOI : 10.1111/j.1464-5491.2011.03532.x
Comprehensive analysis of health related quality of life in patients with diabetes: a study from Konya Turkey, pp.81-88, 2007. ,
Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily, Diabetic Medicine, vol.118, issue.7, pp.722-728, 2009. ,
DOI : 10.1111/j.1464-5491.2009.02752.x
Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment. Diabetes Care, pp.314-319, 2011. ,
Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes, Health and Quality of Life Outcomes, vol.4, issue.1, p.80, 2006. ,
DOI : 10.1186/1477-7525-4-80
Pragmatic Trials ??? Guides to Better Patient Care?, New England Journal of Medicine, vol.364, issue.18, pp.1865-1867, 2011. ,
DOI : 10.1056/NEJMp1103502
Importance of Observational Studies in Clinical Practice, Clinical Therapeutics, vol.29, issue.6, pp.1284-1292, 2007. ,
DOI : 10.1016/j.clinthera.2007.07.004
Observational research methods. Research design II: cohort, cross sectional, and case-control studies, Emergency Medicine Journal, vol.20, issue.1, pp.54-60, 2003. ,
DOI : 10.1136/emj.20.1.54
Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study, Diabetes Therapy, vol.28, issue.1, p.6, 2012. ,
DOI : 10.1007/s13300-012-0006-7
Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE, Diabetes Therapy, vol.344, issue.2 ,
DOI : 10.1007/s13300-013-0037-8
Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries. Diabetes Metab Syn Obesity: Targets and Therapy ,
Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study, ClinicoEconomics and Outcomes Research ,
DOI : 10.2147/CEOR.S44060
Development of a Brief Measure to Assess Quality of Life in Obesity, Obesity Research, vol.97, issue.Suppl 21, pp.102-111, 2001. ,
DOI : 10.1038/oby.2001.13
One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures, Health and Quality of Life Outcomes, vol.7, issue.1, p.53, 2009. ,
DOI : 10.1186/1477-7525-7-53
EuroQol-a new facility for the measurement of healthrelated quality of life. Health Policy, pp.199-208, 1990. ,
Guidelines for analysing and reporting EQ-5D outcomes. In The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective, 2003. ,
DOI : 10.1007/978-94-017-0233-1_2
Adaptation of the Diabetes Health Profile (DHP-1) for use with patients with Type 2 diabetes mellitus: psychometric evaluation and cross-cultural comparison, Diabetic Medicine, vol.20, issue.8, pp.572-580, 2000. ,
DOI : 10.1023/A:1008878031176
The Hospital Anxiety and Depression Scale, Acta Psychiatrica Scandinavica, vol.141, issue.6, pp.361-370, 1983. ,
DOI : 10.1111/j.1600-0447.1983.tb09716.x
Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*, Current Medical Research and Opinion, vol.25, issue.3, pp.691-700, 2009. ,
DOI : 10.1185/03007990902739669
Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme, Diabetes, Obesity and Metabolism, vol.11, issue.S1, pp.77-82, 2012. ,
DOI : 10.1111/j.1463-1326.2011.01493.x
Measurement of health status, Controlled Clinical Trials, vol.10, issue.4, pp.407-415, 1989. ,
DOI : 10.1016/0197-2456(89)90005-6
Methods to Explain the Clinical Significance of Health Status Measures, Mayo Clinic Proceedings, vol.77, issue.4, pp.371-383, 2002. ,
DOI : 10.4065/77.4.371
An assessment of the discriminative ability of the EQ-5D index, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions ,
Estimating the minimally important difference (MID) of the diabetes health profile-18 (DHP-18) for type 1 and type 2 diabetes mellitus. Discussion paper, 2011. ,
The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease, Health and Quality of Life Outcomes, vol.6, issue.1, p.46, 2008. ,
DOI : 10.1186/1477-7525-6-46
An integrated method to determine meaningful changes in health-related quality of life, Journal of Clinical Epidemiology, vol.57, issue.11, pp.1153-1160, 2004. ,
DOI : 10.1016/j.jclinepi.2004.04.004
Industry Advisory Committee of International Society for Quality of Life Research (ISOQOL): Methods for interpreting change over time in patientreported outcome measures, Qual Life Res, 2012. ,
Utilities and disutilities for type 2 diabetes treatment-related attributes, Quality of Life Research, vol.3, issue.Suppl, pp.1251-1265, 2007. ,
DOI : 10.1007/s11136-007-9226-0
Utilities and disutilities for attributes of injectable treatments for type 2 diabetes, The European Journal of Health Economics, vol.4, issue.Suppl 2, pp.219-230, 2011. ,
DOI : 10.1007/s10198-010-0224-8
Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting, Current Medical Research and Opinion, vol.27, issue.12, pp.2335-2342, 2011. ,
DOI : 10.1185/03007995.2011.628305
Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal study, Health and Quality of Life Outcomes, vol.10, issue.1, p.99, 2012. ,
DOI : 10.1186/1477-7525-5-70
Depression, Anxiety and Glucose Metabolism in the General Dutch Population: The New Hoorn Study, PLoS ONE, vol.26, issue.4, p.9971, 2010. ,
DOI : 10.1371/journal.pone.0009971.t005
Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes, Diabetic Medicine, vol.4, issue.4, pp.315-327, 2009. ,
DOI : 10.1111/j.1464-5491.2009.02682.x
The development of an individualized questionnaire measure of perceived ,